Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-423056

Chief Executive Officer sold 4,098 shares at $49.26 ($201,867)

  • Chief Executive Officer acquired 8,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kulkarni Samarth · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-13 Exercise or conversion : show line 1 in the form +8,333 263,834 D
2026-10-14 Sale : show line 2 in the form −4,098 $49.26 $201,867 259,736 D
Open-market sales · 4,098 sh · avg $49.26 · $201,867

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-13 Exercise or conversion : show line 3 in the form Restricted Stock Units −8,333 0 D
Loading xslF345X06/ownership.xml…